Pharmacogenetics of Drug-Resistant Epilepsy (Review of Literature)
Pharmacogenomic studies in epilepsy are justified by the high prevalence rate of this disease and the high cost of its treatment, frequent drug resistance, different response to the drug, the possibility of using reliable methods to assess the control of seizures and side effects of antiepileptic dr...
Guardado en:
Autores principales: | Beata Smolarz, Marianna Makowska, Hanna Romanowicz |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c68f30162e31451aa5392754ce9032a4 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Pharmacogenetic Warfarin Dosing Algorithm in the Russian Population
por: T. A. Bairova, et al.
Publicado: (2019) -
Analysis and Construction of a Molecular Diagnosis Model of Drug-Resistant Epilepsy Based on Bioinformatics
por: Tenghui Han, et al.
Publicado: (2021) -
HDAC4 gene silencing alleviates epilepsy by inhibition of GABA in a rat model
por: Zhang YN, et al.
Publicado: (2019) -
Pharmacogenetics
Publicado: (1991) -
Pharmacogenetic Aspects of Type 2 Diabetes Treatment
por: N. O. Pozdnyakov, et al.
Publicado: (2020)